Palbociclib plus Cetuximab versus placebo plus Cetuximab in platinum resistant, Cetuximab-naive, HPV-unrelated head and neck cancer: A double-blind randomized phase II trial (PALATINUS)
Key publications on targeted therapy in head and neck cancers
Chairpersons :
R. Gopal, S. H. Advani
Reviewer :
Nikhil Pande